Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janet Woodcock
Janet Woodcock
Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA
BioSpace
Mon, 04/19/21 - 11:19 am
FDA
COVID-19
Janet Woodcock
Janet Woodcock on if the FDA is getting tougher on drug reviews: ‘I don’t think so’
Endpoints
Wed, 04/14/21 - 09:49 pm
FDA
Janet Woodcock
drug approvals
Biden is looking beyond Woodcock or Sharfstein for FDA commissioner — report
Endpoints
Thu, 02/25/21 - 09:55 am
FDA
Joe Biden
Janet Woodcock
Joshua Sharfstein
Who Will Be the Next F.D.A. Chief?
NY Times, NY
Mon, 02/22/21 - 11:54 pm
FDA
Joe Biden
Janet Woodcock
Joshua Sharfstein
Joe Biden’s big FDA decision
Vox
Wed, 02/10/21 - 12:12 am
Joe Biden
FDA
Janet Woodcock
Joshua Sharfstein
Woodcock: FDA plans guidance to address new COVID-19 variants
RAPS.org
Sat, 02/6/21 - 11:12 pm
FDA
COVID-19
pandemic
vaccines
drug developments
diagnostics
Janet Woodcock
FDA veteran Janet Woodcock takes over as acting commissioner in Biden administration
Fierce Pharma
Wed, 01/20/21 - 11:23 pm
Janet Woodcock
Joe Biden
FDA
FDA Veteran Being Considered to Lead Agency Under Biden
Bloomberg
Thu, 01/14/21 - 10:26 pm
FDA
Janet Woodcock
Joe Biden
Woodcock: Pharma, regulators have lessons to learn from COVID
RAPS.org
Thu, 11/12/20 - 11:07 pm
Janet Woodcock
pandemic
COVID-19
clinical trials
Emergency Use Authorization
FDA veteran reassigned to vaccine efforts
Beckers Hospital Review
Tue, 05/26/20 - 10:49 am
FDA
Janet Woodcock
COVID-19
vaccines
pandemic
Safeguarding the US Pharmaceutical Supply: Woodcock Discusses Challenges, Shift Overseas
RAPS.org
Wed, 10/30/19 - 11:05 pm
FDA
Janet Woodcock
‘It’s not working': An FDA insider’s view of where medical innovation falls short
LA Times, CA
Mon, 09/9/19 - 10:23 am
FDA
innovation
Janet Woodcock
Not With A Bang, But A Whimper . . . FDA Capitulates On Off-Label Regulation
Forbes
Mon, 11/26/18 - 12:32 pm
FDA
free speech
off-label
Janet Woodcock
FDA's Woodcock: 'The clinical trial system is broken'
Biopharma Dive
Wed, 11/21/18 - 09:54 am
FDA
Janet Woodcock
clinical trials
Reorganization of OND to support new drug review modernization, Woodcock says
Endpoints
Mon, 10/8/18 - 10:43 am
FDA
OND
Janet Woodcock
drug reviews
FDA’s Janet Woodcock: the clinical trials system is ‘broken’
Endpoints
Wed, 09/20/17 - 11:10 pm
FDA
Janet Woodcock
clinical trials
The Woman Behind Sarepta Therapeutics' Success
Motley Fool
Mon, 09/26/16 - 09:38 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Kyndrisa
FDA
Janet Woodcock
FDA’s Woodcock: ‘No connection’ between new drug access policy, Sarepta drug decision
Bizjournals.com
Fri, 06/3/16 - 09:52 pm
FDA
Sarepta Therapeutics
Janet Woodcock
Duchenne Muscular Dystrophy
eteplirsen
We Have A Plan To Reduce Drug Shortages: FDA’s Woodcock Explains
Pharmalot
Wed, 09/30/15 - 09:30 am
drug shortages
FDA
Janet Woodcock
FDA's Woodcock: I'm not going anywhere
Fierce Biotech
Fri, 10/11/13 - 12:08 pm
FDA
Janet Woodcock
Pages
« first
‹ previous
1
2
3
next ›
last »